REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/12/2025
Back to search
Official data from USPTO
ENFUEGO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENFUEGO THERAPEUTICS
ST13
US500000088358357Class
42
Filing
88358357
Registration
6054545
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
05/13/2025
Trademark type
Word
Nice classes
42
Filing date
03/27/2019
Registration date
05/12/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2020
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/17/2019
First use in commerce
11/17/2019
Drawing code
4
Owner type
03
Owner location
Raleigh, NC
Examiner
CHISOLM, KEVON
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Enfuego Therapeutics, Inc.
Representatives
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological servicesscientific researchdesignanalysis and testing in the field of cancer and new cancer therapies using RNA interference; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of RNA in cells within a laboratory or research facility to enable gene expression manipulation to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; Conducting research and clinical trials for others relating to the use and the engineering of RNADNA or the combination for cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposesthe collectiontesting and research of patient molecular and genomic data; collection and preservation of human and animal DNA for research purposes; providing a website featuring health and healthcare information related to cancer research
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/09/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/08/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/14/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/14/2020
IUAF
USE AMENDMENT FILED
02/25/2020
EISU
TEAS STATEMENT OF USE RECEIVED
02/25/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/16/2019
PUBO
PUBLISHED FOR OPPOSITION
07/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/26/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/07/2019
ALIE
ASSIGNED TO LIE
06/07/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/07/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
06/07/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/07/2019
DOCK
ASSIGNED TO EXAMINER
06/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2019
NWAP
NEW APPLICATION ENTERED
03/30/2019
Continuous trademark protection
Get notified about every new filing that threatens ENFUEGO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.